(Q45714364)

15 December 2017

CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma: results of a phase II study (English)

1 reference

15 December 2017

1 reference

1

Jaffer A Ajani

1 reference

15 December 2017

Jackie Baker

2

1 reference

15 December 2017

Peter W T Pisters

3

1 reference

15 December 2017

Linus Ho

4

1 reference

15 December 2017

Paul F Mansfield

5

1 reference

15 December 2017

Barry W Feig

6

1 reference

15 December 2017

Chusilp Charnsangavej

7

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

15 December 2017

1 reference

15 December 2017

94

1 reference

15 December 2017

3

1 reference

15 December 2017

641-646

1 reference

15 December 2017

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10279

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10279

Initial or delayed chemotherapy with best supportive care in advanced gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10279

A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10279

Optimal two-stage designs for phase II clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10279

Phase I-II study of irinotecan hydrochloride combined with cisplatin in patients with advanced gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10279

Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10279

Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10279

Phase I clinical and pharmacologic study of weekly cisplatin combined with weekly irinotecan in patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10279

21 January 2018

Identifiers

DOI

10.1002/CNCR.10279

1 reference

15 December 2017

1 reference